Evaluation of Chitotriosidase and Neopterin as Biomarkers of Microvascular Complications in Patients with Type 1 Diabetes Mellitus.

chitotriosidase diabetes mellitus inflammation microvascular complications neopterin

Journal

Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402

Informations de publication

Date de publication:
08 Feb 2021
Historique:
received: 12 01 2021
revised: 01 02 2021
accepted: 03 02 2021
entrez: 11 2 2021
pubmed: 12 2 2021
medline: 12 2 2021
Statut: epublish

Résumé

The chronic complications of diabetes mellitus (DM) are accompanied by inflammatory manifestations. Our study aimed to evaluate a possible association between the inflammatory status (reflected by serum chitotriosidase and neopterin) and the timely evolution and occurrence of chronic microvascular complications in patients with type 1 DM. This observational, cross-sectional study included 82 type 1 DM patients from the Centre for Diabetes, Nutrition and Metabolic Diseases, Cluj-Napoca, Romania. Our results demonstrated a link between the extent of inflammation, evaluated by the enzymatic activity of circulating chitotriosidase, and the onset of microvascular complications, especially diabetic neuropathy and retinopathy. Chitotriosidase enzymatic activity showed an ascending evolution over time. In non-smoking patients, the increase in chitotriosidase activity was correlated with the extent of microalbuminuria and the decline of glomerular filtration rate, while in smokers, only the presence of a positive correlation between chitotriosidase activity and disease progression was noticed. According to our results, the time span between the moment of diagnosis and the onset of microvascular complications was longer in non-smokers than in smokers. These results also imply that increased chitotriosidase activity may be a predictor of endothelial dysfunction in type 1 DM.

Identifiants

pubmed: 33567717
pii: diagnostics11020263
doi: 10.3390/diagnostics11020263
pmc: PMC7916086
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Curr Vasc Pharmacol. 2011 Mar;9(2):188-99
pubmed: 21143176
Endocr J. 2013;60(1):73-9
pubmed: 22986489
Nat Rev Immunol. 2008 Dec;8(12):958-69
pubmed: 19029990
Clin Chim Acta. 2015 May 20;445:107-14
pubmed: 25818244
Biochem Pharmacol. 1998 Apr 15;55(8):1139-49
pubmed: 9719467
Ann Clin Lab Sci. 2017 Nov;47(6):713-719
pubmed: 29263045
J Gerontol A Biol Sci Med Sci. 2013 Oct;68(10):1303-9
pubmed: 23525479
Diabetes Metab Syndr. 2017 Nov;11 Suppl 1:S503-S506
pubmed: 28392356
Kidney Int. 2015 Jan;87(1):20-30
pubmed: 24786708
J Epithel Biol Pharmacol. 2012;5:1-9
pubmed: 23439988
Kidney Int. 1998 Jul;54(1):193-202
pubmed: 9648079
Int Immunopharmacol. 2018 Jun;59:68-75
pubmed: 29627577
Ophthalmologica. 2019;241(2):90-97
pubmed: 30130755
Scand J Clin Lab Invest. 2017 Jul;77(4):275-282
pubmed: 28319420
Arch Med Sci. 2016 Oct 1;12(5):977-984
pubmed: 27695487
Nat Rev Nephrol. 2011 Jun;7(6):327-40
pubmed: 21537349
Pediatr Nephrol. 2016 Apr;31(4):623-31
pubmed: 26525196
Annu Rev Physiol. 2011;73:479-501
pubmed: 21054166
J Clin Invest. 1994 Mar;93(3):1288-92
pubmed: 8132768
Inflamm Res. 2003 Aug;52(8):313-21
pubmed: 14504669
Diabetes Care. 2010 Oct;33(10):2285-93
pubmed: 20876709
Curr Drug Metab. 2002 Apr;3(2):175-87
pubmed: 12003349
Endocrine. 2010 Jun;37(3):455-9
pubmed: 20960168
Biomarkers. 2015 Feb;20(1):52-7
pubmed: 25519006
J Autoimmun. 2010 May;34(3):J258-65
pubmed: 20042314
World J Diabetes. 2013 Dec 15;4(6):290-4
pubmed: 24379919
Pathobiology. 2016;83(4):211-9
pubmed: 27116685
Clin Biochem. 2016 Apr;49(6):444-448
pubmed: 26589000

Auteurs

Ancuța Cutaș (A)

Department of Medical Informatics and Biostatistics, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.

Cristina Drugan (C)

Department of Medical Biochemistry, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.

Gabriela Roman (G)

Department of Diabetes, Nutrition and Metabolic Diseases, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.

Adriana Rusu (A)

Department of Diabetes, Nutrition and Metabolic Diseases, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.

Cristina Sorina Cătană (CS)

Department of Medical Biochemistry, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.

Andrei Achimaș-Cadariu (A)

Department of Medical Informatics and Biostatistics, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.

Tudor Drugan (T)

Department of Medical Informatics and Biostatistics, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.

Classifications MeSH